GSK plc
GSK
$38.40
$0.441.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.05B | 530.19M | -75.48M | 1.48B | 1.33B |
| Total Depreciation and Amortization | 1.04B | 257.41M | 1.24B | 806.10M | 696.16M |
| Total Amortization of Deferred Charges | -- | 270.22M | -- | -- | -- |
| Total Other Non-Cash Items | 123.43M | 2.54B | -524.43M | -475.59M | -38.04M |
| Change in Net Operating Assets | -1.76B | -613.43M | 2.17B | -406.20M | -769.71M |
| Cash from Operations | 1.44B | 2.98B | 2.80B | 1.40B | 1.21B |
| Capital Expenditure | -261.97M | -696.68M | -396.90M | -380.97M | -314.48M |
| Sale of Property, Plant, and Equipment | 1.26M | 78.12M | 1.30M | 2.52M | 1.27M |
| Cash Acquisitions | -1.01B | -83.24M | -5.21M | -41.63M | -915.53M |
| Divestitures | -1.26M | -6.40M | -3.90M | -8.83M | -3.80M |
| Other Investing Activities | -167.51M | -724.85M | -546.55M | 1.40B | 1.04B |
| Cash from Investing | -1.44B | -1.43B | -951.26M | 971.36M | -188.94M |
| Total Debt Issued | 2.08B | 1.34B | -- | -- | -- |
| Total Debt Repaid | -216.00M | -1.15B | -604.00M | -596.00M | -380.00M |
| Issuance of Common Stock | 12.00M | 0.00 | 1.00M | 1.00M | 18.00M |
| Repurchase of Common Stock | -247.00M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -770.80M | -783.76M | -796.40M | -822.50M | -720.25M |
| Other Financing Activities | -156.00M | -418.00M | -25.00M | -337.00M | -130.00M |
| Cash from Financing | 1.08B | -1.08B | -1.61B | -2.00B | -1.34B |
| Foreign Exchange rate Adjustments | -13.85M | 8.96M | -44.24M | -10.09M | -24.09M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.07B | 480.25M | 193.90M | 367.10M | -342.37M |